How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Melting pot, tapestry, mosaic, kaleidoscope, salad bowl. Every cliché is true. Melting pot, tapestry, mosaic, kaleidoscope, salad bowl. Every cliché is true. By Albert Sun, Jeff Adelson and Larry ...

Trace William Cowen is a writer whose work has also appeared in Alternative Press, Uproxx, and elsewhere. As Complex's Senior News Writer, Trace pens everything from quick news hits to expansive ...

A FOX News original, Gallagher joined FNC at the network’s launch in 1996 and has covered breaking news stories throughout the past 26 years. On Inauguration Day 2025, he contributed to the extensive ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...